Carlotta Galeone
YOU?
Author Swipe
View article: Supporting treatment decision-making for patients with multiple myeloma post-DRd in Italy: a multi-criteria decision framework
Supporting treatment decision-making for patients with multiple myeloma post-DRd in Italy: a multi-criteria decision framework Open
This study provides valuable insights into the post-DRd treatment landscape for Multiple Myeloma, supporting decision-making from an Italian multi-stakeholder perspective.
View article: Estimation of patients potentially eligible for icosapent ethyl therapy in Italy through a review of literature data
Estimation of patients potentially eligible for icosapent ethyl therapy in Italy through a review of literature data Open
Introduction: The literature and international Guidelines agree in identifying LDL cholesterol (LDL-C) control asthe primary goal for reducing cardiovascular (CV) risk, while hypertriglyceridemia management is a secondaryobjective. Neverth…
View article: Rising Unmet Need in Multiple Myeloma Management After First-Line Treatment With DRd: Expected Epidemiological Evolution in Italy
Rising Unmet Need in Multiple Myeloma Management After First-Line Treatment With DRd: Expected Epidemiological Evolution in Italy Open
View article: Polihexanide (PHMB) 0.08% versus currently used treatments for <i>Acanthamoeba</i> keratitis: indirect treatment comparisons
Polihexanide (PHMB) 0.08% versus currently used treatments for <i>Acanthamoeba</i> keratitis: indirect treatment comparisons Open
Background/aims Acanthamoeba keratitis is a rare, severe corneal infection. Until the recent approval of polihexanide (PHMB) 0.08% by the European Medicines Agency, there were no licensed medical therapies and current treatments relied on …
View article: Epidemiology and Severity of Prurigo Nodularis In Europe: A Literature Review With an Application to Italian Data
Epidemiology and Severity of Prurigo Nodularis In Europe: A Literature Review With an Application to Italian Data Open
Introduction: Prurigo nodularis (PN) is a chronic inflammatory skin disease with recent definition and relatively low prevalence. Information on PN, including its epidemiology, severity, and burden of disease is still scanty. Objectives: W…
View article: Epidemiology and Severity of Prurigo Nodularis In Europe: A Literature Review With an Application to Italian Data
Epidemiology and Severity of Prurigo Nodularis In Europe: A Literature Review With an Application to Italian Data Open
Introduction: Prurigo nodularis (PN) is a chronic inflammatory skin disease with recent definition and relatively low prevalence. Information on PN, including its epidemiology, severity, and burden of disease is still scanty. Objectives: W…
View article: The role of Fraction Exhaled Nitric Oxide (FeNO) in asthma management: an Italian consensus statement on clinical and economic aspects
The role of Fraction Exhaled Nitric Oxide (FeNO) in asthma management: an Italian consensus statement on clinical and economic aspects Open
Background: Chronic respiratory diseases cause significant global morbidity and mortality, with asthma being a major contributor. Globally, 461,000 asthma-related deaths and a prevalence of 262 million subjects were estimated in 2019. The …
View article: Is It Time to Reconsider the Prognostic Role of Mitotic Rate in Cutaneous Malignant Melanoma? Evidence from a Multicenter Study on Behalf of Italian Melanoma Intergroup
Is It Time to Reconsider the Prognostic Role of Mitotic Rate in Cutaneous Malignant Melanoma? Evidence from a Multicenter Study on Behalf of Italian Melanoma Intergroup Open
View article: Determinants Of Survival, Clinicopathological Features And Potential Risk Factors For Multiple Primary Melanoma Patients Compared To Single Primary Melanoma: A Large Single-centre Study
Determinants Of Survival, Clinicopathological Features And Potential Risk Factors For Multiple Primary Melanoma Patients Compared To Single Primary Melanoma: A Large Single-centre Study Open
View article: Faricimab versus the standard of care for neovascular age-related macular degeneration in Italy: an indirect treatment comparison
Faricimab versus the standard of care for neovascular age-related macular degeneration in Italy: an indirect treatment comparison Open
Objectives: To assess through an indirect treatment comparison (ITC) the potential benefit of faricimab over the anti-vascular endothelial growth factor (VEGF) real-life scenario, hereby defined standard of care (SoC), in Italy, that is, a…
View article: Epidemiology, management and patient needs in myasthenia gravis: an Italian multistakeholder consensus based on Delphi methodology
Epidemiology, management and patient needs in myasthenia gravis: an Italian multistakeholder consensus based on Delphi methodology Open
Objectives To provide comprehensive information on the burden of myasthenia gravis (MG) in Italy, including the unmet needs of patients and several other aspects related to the disease, based on skilled viewpoints of MG experts. Design Ite…
View article: Upright to supine image registration and contour propagation for thoracic patients
Upright to supine image registration and contour propagation for thoracic patients Open
A renewed interest in upright therapy is currently driven by the availability of upright positioning and imaging systems. Aside from reduced cost, upright positioning possibly provides clinical advantages. The comparison between upright an…
View article: Use of a Digital Medical Device to Improve Therapeutic Adherence in Patients with Hematological Malignancies: the MargheRITA Study (Preprint)
Use of a Digital Medical Device to Improve Therapeutic Adherence in Patients with Hematological Malignancies: the MargheRITA Study (Preprint) Open
BACKGROUND Oncological conditions are a global health challenge, with a substantial number of deaths each year. Treatment adherence is crucial for improving patient outcomes in patients with hematological malignancies, but resource limita…
View article: Correction: From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy
Correction: From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy Open
View article: From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy
From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy Open
The negotiation for new indications takes longer than the first one, and provides, on average, an additional discount of 13%. While our findings bear the potential for significant policy implications, they necessitate prudent interpretatio…
View article: Study protocol of a clinical randomized controlled trial on the efficacy of an innovative Digital thErapy to proMote wEighT loss in patients with obesity by incReasing their Adherence to treatment: the DEMETRA study
Study protocol of a clinical randomized controlled trial on the efficacy of an innovative Digital thErapy to proMote wEighT loss in patients with obesity by incReasing their Adherence to treatment: the DEMETRA study Open
Despite the increasing importance of innovative medications and bariatric surgery for the treatment of obesity, lifestyle interventions (diet and physical activity) remain the first-line therapy for this disease. The use of digital devices…
View article: Time to market access in Italy: duration of the P&R process for rare disease drugs
Time to market access in Italy: duration of the P&R process for rare disease drugs Open
Objective: This paper aims to investigate the duration of the pricing & reimbursement (P&R) procedures submitted in Italy by pharmaceutical marketing authorization holders (MAH) for drugs indicated for rare diseases. Methods: All the data …
View article: Atopic Dermatitis in Italian Pre-School Children: Literature Review of Epidemiological Data with a Focus on Disease Prevalence and Severity
Atopic Dermatitis in Italian Pre-School Children: Literature Review of Epidemiological Data with a Focus on Disease Prevalence and Severity Open
Atopic dermatitis (AD) is one of the most common diseases worldwide. Severe AD has a major impact on the quality of life of patients. We performed a systematic literature review on the epidemiology of AD in Italian pre-school children (age…
View article: Figure S2 from Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study
Figure S2 from Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study Open
Figure S2 shows OS in strata of MSC risk level in patients with PD-L1>=50% and with PD-L1<50%
View article: Data from Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study
Data from Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study Open
Purpose:Immune-checkpoint inhibitors (ICI) have improved the survival of patients with non–small cell lung cancer (NSCLC). However, only a subset of patients benefit from ICIs, and the role of PD-L1 as predictive biomarker is still debated…
View article: Data from Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study
Data from Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study Open
Purpose:Immune-checkpoint inhibitors (ICI) have improved the survival of patients with non–small cell lung cancer (NSCLC). However, only a subset of patients benefit from ICIs, and the role of PD-L1 as predictive biomarker is still debated…
View article: Figure S1 from Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study
Figure S1 from Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study Open
Figure S1 reports PFS and OS of the whole series
View article: Figure S2 from Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study
Figure S2 from Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study Open
Figure S2 shows OS in strata of MSC risk level in patients with PD-L1>=50% and with PD-L1<50%
View article: Supplementary Tables from Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study
Supplementary Tables from Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study Open
Supplementary Table S1, Table S2 and Table S3
View article: Supplementary Tables from Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study
Supplementary Tables from Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study Open
Supplementary Table S1, Table S2 and Table S3
View article: Figure S1 from Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study
Figure S1 from Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study Open
Figure S1 reports PFS and OS of the whole series
View article: Figure S3 from Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study
Figure S3 from Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study Open
Figure S3 shows the trend of the MSC risk level in course of treatment with ICIs
View article: Figure S3 from Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study
Figure S3 from Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study Open
Figure S3 shows the trend of the MSC risk level in course of treatment with ICIs
View article: Acid sphingomyelinase deficiency (ASMD): addressing knowledge gaps in unmet needs and patient journey in Italy—a Delphi consensus
Acid sphingomyelinase deficiency (ASMD): addressing knowledge gaps in unmet needs and patient journey in Italy—a Delphi consensus Open
View article: The Evaluation of Drug Innovativeness in Italy: Key Determinants and Internal Consistency
The Evaluation of Drug Innovativeness in Italy: Key Determinants and Internal Consistency Open
Innovativeness status is driven by the added therapeutic value and quality of evidence. The appraisal process is internally consistent and predictable. This provides industry with a clear indication of what is needed to ensure that access …